101 related articles for article (PubMed ID: 15209630)
1. Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.
Kalekou H; Miliaras D
J Gastroenterol Hepatol; 2004 Jul; 19(7):812-8. PubMed ID: 15209630
[TBL] [Abstract][Full Text] [Related]
2. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
Gong Y; Sun X; Huo L; Wiley EL; Rao MS
Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of p53 and c-erbB2 in geriatric women with cervical carcinoma].
Huang YW; Li MD; Wu QL; Liu FY
Ai Zheng; 2002 Mar; 21(3):297-300. PubMed ID: 12451999
[TBL] [Abstract][Full Text] [Related]
5. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
[TBL] [Abstract][Full Text] [Related]
6. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
[TBL] [Abstract][Full Text] [Related]
7. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
Tomaszewska R; Nowak K; Stachura J
Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
[TBL] [Abstract][Full Text] [Related]
8. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer.
Chan JK; Loizzi V; Magistris A; Lin F; Rutgers J; Osann K; Disaia PJ; Berman ML
Clin Cancer Res; 2004 Dec; 10(24):8538-43. PubMed ID: 15623636
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer.
Tanaka S; Tanaka H; Yamamoto T; Shuto T; Takemura S; Hai S; Sakabe K; Uenishi T; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):228-34. PubMed ID: 16708300
[TBL] [Abstract][Full Text] [Related]
10. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
11. Correlation between P53 expression and CD34 angiogenic factor in Tunisian breast cancer.
Fourati A; Khomsi F; El May MV; Rahal K; Gamoudi A; Boussen H; Ben Abdallah M; El May A
Tunis Med; 2007 Feb; 85(2):105-8. PubMed ID: 17665654
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of p53, c-erbB2, CEA proteins in colorectal adenoma and carcinoma].
Shu M; Liu S; Yu P
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):129-32. PubMed ID: 10681823
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
[TBL] [Abstract][Full Text] [Related]
14. The significance of CD44 expression in gastrointestinal neuroendocrine tumors.
Lai CH; Shan YS; Sy ED; Hsieh YH; Tsai HW; Lee JC; Lin PW
Hepatogastroenterology; 2005; 52(64):1071-6. PubMed ID: 16001632
[TBL] [Abstract][Full Text] [Related]
15. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
16. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.
Wang SN; Chung SC; Tsai KB; Chai CY; Chang WT; Kuo KK; Chen JS; Lee KT
Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721
[TBL] [Abstract][Full Text] [Related]
17. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; RabczyƱski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors.
Sun X; Gong Y; Talamonti MS; Rao MS
Mod Pathol; 2002 Dec; 15(12):1333-8. PubMed ID: 12481015
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
20. Role of C-erbB2 expression in gallbladder cancer.
Kumari N; Kapoor VK; Krishnani N; Kumar K; Baitha DK
Indian J Pathol Microbiol; 2012; 55(1):75-9. PubMed ID: 22499306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]